Protein That Increases Breast Cancer Spread Has Been Identified

UC Davis Cancer Center researchers have identified a protein that may allow breast cancer to spread and make it resistant to drugs.

The research team led by Kermit Carraway have discovered a protein called Muc4, which belongs to a group of proteins called mucins, commonly found in fluids such as tears and mucus.

About Cancer in Women
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.

"Breast cancer deaths are caused by metastasis, not by the primary tumor," said Carraway.

"It's at that point that the disease also becomes difficult to treat. We think that Muc4 may be packing a one-two punch by promoting the release of breast cancer cells from the primary tumor and then inhibiting their death," he added.

During the study, the researchers conducted two experiments.

Scientists Identify New Drug Target Against Virulent Type of Breast Cancer
Researchers at Cold Spring Harbor Laboratory have identified an enzyme called Brk - shown to be an accelerator of HER2-positive tumours - that may serve as a potential drug target

In the first experiment, they compared breast cancer cells that express Muc4 with those for which Muc4 production is blocked.

The researchers then exposed both types of cells to chemotherapy drugs and found that Muc4-producing cells survived.

Breast Cancer Spread Halted by Targeted Therapy
A therapy targeting a protein, called cyclin D1, may block the expansion of breast cancer stem cells.

In the second experiment, they compared breast cancer cells and epithelial cells that do not naturally express Muc4 but were engineered to do so.

"Our results lead us to believe that Muc4 is somehow disrupting normal links between epithelial cells," said UC Davis graduate student Heather Workman, lead author of the study.

"We now need to refine our understanding of this disruption process in order to find ways to interfere with it. There currently are no drugs that target Muc4, and this research will help change that," she added.

For further understanding, Carraway is preparing to test metastasizing breast cancer tumor cells for the overexpression of Muc4.

"If we find that Muc4 is all over metastasizing breast cancer cells, it will confirm that we are on the right track," he said.

The study appears Cancer Research.

Source-ANI
ARU/L